by Jordana Choucair | Jun 7, 2022 | Life Sciences
Pfizer announced that it is investing $120 million to boost production of its Paxlovid COVID-19 treatment pills in the U.S. To date, Pfizer has shipped 12 million courses globally to 37 countries, including 5 million to the U.S. The investment will allow Pfizer to add...
by Jordana Choucair | Jun 7, 2022 | Providers
The American Health Care Association released survey data indicating that nursing homes across the U.S. are facing closure risks amid staff shortages and higher operating costs. The survey found that nearly 60 percent of nursing homes in the U.S. are operating at a...
by Jordana Choucair | Jun 7, 2022 | Public Health/Prevention
According to data from the Centers for Disease Control and Prevention (CDC), the U.S. has waster more than 82 million doses of COVID-19 vaccines since the onset of the pandemic. The new figure translates to approximately 11 percent of doses distributed by the federal...
by Jordana Choucair | Jun 7, 2022 | Public Health/Prevention
Leading Republican senators involved in gun talks on Capitol Hill have signaled that it’s unlikely Congress will raise the age requirement for purchasing semi-automatic firearms from 18 to 21. Senators John Cornyn and Thom Tillis both said proposals to ban...
by Jordana Choucair | Jun 6, 2022 | Life Sciences
Prime Therapeutics released a new study suggesting that using a medically-integrated dispensing (MID) model could yield significant savings.Under a MID model, care providers have access to prescribing history, test results, and other patient history in the electronic...
by Jordana Choucair | Jun 6, 2022 | Life Sciences
Abbott Nutrition announced on Saturday that it will resume producing infant formula at its Michigan facility. Abbott said in a statement that initial requirements of the consent agreement it reached with the Food and Drug Administration (FDA) last month had been met,...
Recent Comments